Ovid Therapeutics Inc (OVID)
3.005
-0.04
(-1.48%)
USD |
NASDAQ |
May 10, 16:00
3.005
0.00 (0.00%)
After-Hours: 18:26
Ovid Therapeutics Cash and Short Term Investments (Quarterly): 105.83M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 105.83M |
| September 30, 2023 | 87.07M |
| June 30, 2023 | 96.52M |
| March 31, 2023 | 117.72M |
| December 31, 2022 | 129.00M |
| September 30, 2022 | 137.86M |
| June 30, 2022 | 152.37M |
| March 31, 2022 | 166.67M |
| December 31, 2021 | 187.80M |
| September 30, 2021 | 201.78M |
| June 30, 2021 | 212.17M |
| March 31, 2021 | 233.05M |
| December 31, 2020 | 72.03M |
| September 30, 2020 | 86.87M |
| June 30, 2020 | 41.25M |
| Date | Value |
|---|---|
| March 31, 2020 | 58.33M |
| December 31, 2019 | 76.74M |
| September 30, 2019 | 37.91M |
| June 30, 2019 | 47.36M |
| March 31, 2019 | 59.64M |
| December 31, 2018 | 41.50M |
| September 30, 2018 | 52.51M |
| June 30, 2018 | 62.59M |
| March 31, 2018 | 74.16M |
| December 31, 2017 | 87.13M |
| September 30, 2017 | 96.04M |
| June 30, 2017 | 106.12M |
| March 31, 2017 | 44.23M |
| December 31, 2016 | 51.94M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
37.91M
Minimum
Sep 2019
233.05M
Maximum
Mar 2021
118.33M
Average
105.83M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 310.59M |
| NovaBay Pharmaceuticals Inc | 3.13M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |
| Theriva Biologics Inc | 23.18M |